Considering Biosimilars: Exploring Perceptions and Potential Adoption

Watch the lively discussion on the future of biosimilars in the U.S., especially as the FDA prepares for another round of public hearings. Panelists addressed the attitudes of current biologic prescribers, key considerations for biosimilars adoption, such as pricing of approved biosimilars, and potential pricing and market barriers to biosimilars acceptance.

The webinar focused on questions of:

  • Interchangeability rules
  • When should clinicians switch from branded biologics to a biosimilar
  • What are the real price savings for patients
  • The role of payors in biosimilar adoption

Contact us if you would also like a full copy of our syndicated survey report!

    InCrowd uses the information you provide to us to contact you about our relevant insights, products, and services. You may opt out of communications at any time via the unsubscribe link at the bottom of any email or by sending an email withdrawing your consent to Send Email. For more information, please review our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.